A DNA injection against obesity could replace weekly bites in millions of patients. This is suggested by work by the Philadelphia Wistar Institute, published in June 2026. Their plasmid DNA maintains its effects far beyond semaglutide in diabetic mice. The study remains preclinical, but it could alleviate the burden of repeated treatments for type 2 diabetes and overweight, two diseases that affect hundreds of millions of people. A single DNA in…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A DNA injection against obesity could replace weekly bites in millions of patients. This is suggested by work by the Philadelphia Wistar Institute, published in June 2026. Their plasmid DNA maintains its effects far beyond semaglutide in diabetic mice. The study remains preclinical, but it could alleviate the burden of repeated treatments for type 2 diabetes and overweight, two diseases that affect hundreds of millions of people. A single DNA in…